or
Remember me
Back
CNBC report on Biden's plan: Abbott Labs is on contract in the US. This is a company with a platform the same as THRM. Their stock trades over $105US. The plans also suggests significantly increasing the nation's testing by doubling the number of drive-through sites — at least 10 per state — and investing in at-home tests. So far, the nation's coronavirus response has depended on molecular tests that require lab equipment and trained personnel. The White House announced in August that it would buy 150 million rapid tests as part of a $750 million agreement with Abbott Laboratories.
A daily snapshot of everything from market open to close.